Identification of Subclinical Microvascular Biomarkers in Coronary Heart Disease in Retinal Imaging

Julia Aschauer1,2, Stefan Aschauer3, Andreas Pollreisz1,2

  • 1Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Insights

Retinal microvascular imaging can detect subclinical signs of coronary heart disease (CHD). This non-invasive approach may help identify individuals at risk for cardiovascular disease, aiding in early diagnosis and management.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Medical Imaging

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Early detection of CHD risk factors is crucial for effective cardiovascular disease management.
  • Non-invasive imaging techniques offer potential for early disease identification.

Purpose of the Study:

  • To investigate the utility of multimodal retinal imaging in identifying microvascular features associated with coronary angiography (CA)-confirmed CHD.
  • To define subclinical retinal microvascular changes in patients with and without CHD.

Main Methods:

  • Prospective, cross-sectional pilot study involving adult patients undergoing elective CA for suspected CHD.
  • Utilized widefield fundus photography, optical coherence tomography angiography (OCTA), and adaptive optics imaging.
  • Measured retinal vessel density (VD), arteriolar lumen diameter (LD), total diameter (TD), and wall-to-lumen ratio (WLR).

Main Results:

  • 45 patients included; 27 confirmed with CHD.
  • Prevalent retinal pathologies included arteriovenous nickings, arterial narrowings, and microaneurysms.
  • Lower VD in superficial, deep, and choriocapillaris plexuses observed in CHD patients; a trend toward higher WLR in CHD patients was noted.

Conclusions:

  • High-resolution retinal microvascular phenotyping may serve as a valuable subclinical indicator of coronary artery impairment in cardiovascular risk populations.
  • Larger clinical trials are necessary to validate these findings.
  • Subclinical retinal changes can act as non-invasive biomarkers for CHD risk stratification.
Abstract

Related Concept Videos